Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein

Cell Cycle

Volumn 12, Issue 10, 2013, Pages 1569-1577

  Bagashev, Asen ^a   Fan, Shongshan ^a   Mukerjee, Ruma ^a   Claudio, Pier Paolo ^b   Chabrashvili, Tinatin ^c   Leng, Roger P ^d   Benchimol, Samuel ^e   Sawaya, Bassel E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e YORK UNIVERSITY   (Canada)

Author keywords

Cdk9; HIV 1; P53; Pirh2; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE 9; PIRH2 PROTEIN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; MDM2 PROTEIN, HUMAN; RCHY1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL CYCLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; MICROGLIA; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION ELONGATION; UBIQUITINATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CELL LINE; GENETIC TRANSFECTION; GENETICS; LONG TERMINAL REPEAT; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN ANALYSIS; RNA INTERFERENCE;

AMINO ACID SEQUENCE; CELL LINE; CYCLIN-DEPENDENT KINASE 9; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-MDM2; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84877991350     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24733     Document Type: Article

References (36)

1. Graña X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, et al. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci USA 1994; 91:3834-8; PMID:8170997; http://dx.doi.org/10.1073/pnas.91.9.3834
2. Bullrich F, MacLachlan TK, Sang NL, Druck T, Veronese ML, Allen SL, et al. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res 1995; 55:1199-205; PMID:7882308
3. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92:451-62; PMID:9491887; http://dx.doi.org/10.1016/S0092-8674(00)80939-3
4. Nguyen VT, Kiss TS, Michels AA, Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 2001; 414:322-5; PMID:11713533; http://dx.doi.org/10.1038/35104581
5. Claudio PP, Cui J, Ghafouri M, Mariano C, White MK, Safak M, et al. Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol 2006; 208:602-12; PMID:16741955; http://dx.doi.org/10.1002/jcp.20698
6. Chang PC, Li M. Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor. J Virol 2008; 82:278-90; PMID:17942552; http://dx.doi.org/10.1128/ JVI.01552-07
7. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 2000; 275:279-87; PMID:10617616; http://dx.doi.org/ 10.1074/jbc.275.1.279
8. Fu TJ, Peng JM, Lee G, Price DH, Flores O. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J Biol Chem 1999; 274:34527-30; PMID:10574912; http://dx.doi.org/10.1074/jbc.274.49. 34527
9. Napolitano G, Licciardo P, Gallo P, Majello B, Giordano A, Lania L. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS 1999; 13:1453-9; PMID:10465067; http://dx.doi.org/10.1097/00002030- 199908200-00003
10. Kubbutat MHG, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303; PMID:9153396; http://dx.doi.org/10.1038/387299a0
11. Leng RP, Lin YP, Ma WL, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112:779-91; PMID:12654245; http://dx.doi.org/10.1016/S0092-8674(03)00193-4
12. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429:86-92; PMID:15103385; http://dx.doi.org/10.1038/nature02514
13. Chen DL, Kon N, Li MY, Zhang WZ, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005; 121:1071-83; PMID:15989956; http://dx.doi.org/10.1016/j.cell.2005.03.037
14. Jung YS, Liu G, Chen X. Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. Mol Cell Biol 2010; 30:1041-8; PMID:20008555; http://dx.doi.org/10.1128/MCB.01198-09
15. Duan S, Yao Z, Hou D, Wu Z, Zhu WG, Wu M. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. EMBO J 2007; 26:3062-74; PMID:17568776; http://dx.doi.org/10.1038/sj.emboj.7601749
16. Mukerjee R, Claudio PP, Chang JR, Del Valle L, Sawaya BE. Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle 2010; 9:4569-78; PMID:21088492; http://dx.doi.org/10.4161/cc.9.22.13836
17. D'Orso I, Frankel AD. RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation. Nat Struct Mol Biol 2010; 17:815-21; PMID:20562857; http://dx.doi.org/10.1038/nsmb.1827
18. Pauls E, Senserrich J, Clotet B, Esté JA. Inhibition of HIV-1 replication by RNA interference of p53 expression. J Leukoc Biol 2006; 80:659-67; PMID:16844765; http://dx.doi.org/10.1189/jlb.0306189
19. Maya R, Balass M, Kim ST, Shkedy D, Leal JFM, Shifman O, et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 2001; 15:1067-77; PMID:11331603; http://dx.doi.org/10. 1101/gad.886901
20. Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Mol Cell 2006; 21:307-15; PMID:16455486; http://dx.doi.org/10.1016/j.molcel.2006.01.020
21. Brooks CL, Gu W. p53 regulation by ubiquitin. FEBS Lett 2011; 585:2803-9; PMID:21624367; http://dx.doi.org/10.1016/j.febslet.2011.05.022
22. Baumli S, Lolli G, Lowe ED, Troiani S, Rusconi L, Bullock AN, et al. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J 2008; 27:1907-18; PMID:18566585; http://dx.doi.org/10.1038/emboj.2008.121
23. Janabi N, Peudenier S, Héron B, Ng KH, Tardieu M. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci Lett 1995; 195:105-8; PMID:7478261; http://dx.doi.org/10.1016/0304-3940(94)11792-H
24. Logan IR, Sapountzi V, Gaughan L, Neal DE, Robson CN. Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome. J Biol Chem 2004; 279:11696-704; PMID:14701804; http://dx.doi.org/10.1074/jbc.M312712200
25. Col E, Caron C, Chable-Bessia C, Legube G, Gazzeri S, Komatsu Y, et al. HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J 2005; 24:2634-45; PMID:16001085; http://dx.doi.org/10.1038/sj. emboj.7600734
26. Sho T, Tsukiyama T, Sato T, Kondo T, Cheng J, Saku T, et al. TRIM29 negatively regulates p53 via inhibition of Tip60. Biochim Biophys Acta 2011; 1813:1245-53; PMID:21463657; http://dx.doi.org/10.1016/j.bbamcr.2011.03.018
27. Zhou MS, Nekhai S, Bharucha DC, Kumar A, Ge H, Price DH, et al. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. J Biol Chem 2001; 276:44633-40; PMID:11572868; http://dx.doi.org/10.1074/jbc.M107466200
28. Brès V, Yoh SM, Jones KA. The multi-tasking P-TEFb complex. Curr Opin Cell Biol 2008; 20:334-40; PMID:18513937; http://dx.doi.org/10.1016/j.ceb. 2008.04.008
29. Radhakrishnan SK, Gartel AL. CDK9 phosphorylates p53 on serine residues 33, 315 and 392. Cell Cycle 2006; 5:519-21; PMID:16552184; http://dx.doi.org/10. 4161/cc.5.5.2514
30. O'Brien SK, Cao H, Nathans R, Ali A, Rana TM. P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes. J Biol Chem 2010; 285:29713-20; PMID:20551309; http://dx.doi.org/10.1074/jbc.M110. 125997
31. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, et al. Regulation of p53 activity through lysine methylation. Nature 2004; 432:353-60; PMID:15525938; http://dx.doi.org/10.1038/nature03117
32. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 1998; 273:20052-7; PMID:9685344; http://dx.doi.org/10.1074/jbc.273.32.20052
33. Sawaya BE, Khalili K, Gordon J, Taube R, Amini S. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 2000; 275:35209-14; PMID:10931842; http://dx.doi.org/10.1074/jbc.M005197200
34. Sawaya BE, Rohr O, Aunis D, Schaeffer E. Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells. J Biol Chem 1996; 271:23572-6; PMID:8798567; http://dx.doi.org/10.1074/jbc.271.38.23572
35. Amini S, Mameli G, Del Valle L, Skowronska A, Reiss K, Gelman BB, et al. p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol 2005; 25:8126-38; PMID:16135803; http://dx.doi.org/10.1128/MCB.25.18.8126-8138.2005
36. Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, et al. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem 2009; 284:11364-73; PMID:19204000; http://dx.doi.org/10.1074/jbc.M809266200